Arne Grumann

Arne has a Ph.D. in organic synthetic chemistry and has wide international experience. He held senior scientist and manager positions at Oxford Asymmetry in England and at AstraZeneca in Sweden in both, drug discovery and drug development. Since 2013, he has led the R&D at Fermion as VP and has served in total 26 years in the pharma industry.